 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | allogenic adipose tissue-derived mesenchymal stem cells expanded / ANd&tAT
Trial completion, Trial completion date, Trial primary completion date: Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 (clinicaltrials.gov) - Apr 6, 2022
P1/2, N=26, Completed, Sponsor: Andalusian Network for Design and Translation of Advanced Therapies
Active, not recruiting --> Completed | Trial completion date: Oct 2021 --> Dec 2021 | Trial primary completion date: Oct 2021 --> Dec 2021
- | allogenic adipose tissue-derived mesenchymal stem cells expanded / ANd&tAT
Enrollment closed: Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 (clinicaltrials.gov) - Nov 30, 2020
P1/2, N=26, Active, not recruiting, Sponsor: Andalusian Network for Design and Translation of Advanced Therapies
Active, not recruiting --> Completed | Trial completion date: Oct 2021 --> Dec 2021 | Trial primary completion date: Oct 2021 --> Dec 2021 Recruiting --> Active, not recruiting
- | allogenic adipose tissue-derived mesenchymal stem cells expanded / ANd&tAT
Enrollment open: Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 (clinicaltrials.gov) - Jun 5, 2020
P1/2, N=26, Recruiting, Sponsor: Andalusian Network for Design and Translation of Advanced Therapies
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | allogenic adipose tissue-derived mesenchymal stem cells expanded / ANd&tAT
New P1/2 trial: Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 (clinicaltrials.gov) - Apr 28, 2020
P1/2, N=26, Not yet recruiting, Sponsor: Andalusian Network for Design and Translation of Advanced Therapies